Diagnostic Accuracy of IGA Anti-Tissue Transglutaminase Antibody Testing in Celiac Disease

Open access

Diagnostic Accuracy of IGA Anti-Tissue Transglutaminase Antibody Testing in Celiac Disease

Contemporary guidelines for the first-line diagnosis of celiac disease recommend determination of IgA anti-tissue transglutaminase antibodies or IgA antiendomysial antibodies, as well as total serum IgA antibodies. The aim of our study was to assess the validity and clinical significance of serological testing for IgA anti-tissue transglutaminase antibodies in the diagnosis of celiac disease, and to investigate the presence of malabsorption symptoms in celiac patients. IgA anti-tissue transglutaminase antibody testing was performed in 50 subjects with clinically suspected celiac disease (21 men and 29 women). All subjects underwent endoscopy with small intestine biopsy. Celiac disease was confirmed by histopathological findings in four subjects, whereas the IgA anti-tissue transglutaminase test was positive in three subjects. The IgA anti-tissue transglutaminase test showed sensitivity of 75% and specificity of 100%. There were significant differences between men with biopsy-confirmed and excluded celiac disease in the erythrocyte parameters MCV (96.5±7.7 vs. 78.6 ±11.3; p<0.05), MCH (36.9±4.6 vs. 25.9±4.9; p<0.01), and MCHC (382.5±16.3 vs. 326.9±19.1; p<0.005), as well as in the levels of total protein (47.5 ±16.3 vs. 68.3 ± 7.6; p<0.01) and albumins (24.6±9.5 vs. 42.1 ± 6.9; p<0.01). In addition, HDL-cholesterol levels were significantly lower in men with biopsy-confirmed celiac disease (0.42.±0.12 vs. 0.90±0.30; p<0.05). Our results show a high correlation between IgA anti-tissue transglutaminase testing and endoscopy with biopsy as the gold diagnostic standard.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • Sugai E Nachman F Vaquez H Gonzalez A Andrenacci P Czech A et al. Dynamics of celiac disease-specific serology after initiation of a gluten-free diet and use in the assessment of compliance with treatment. Dig Liver Dis 2010; 42 (5): 352-8.

  • Greco L Romino R Coto I Di Cosmo N Percopo S Maglio M et al. The first large population based twin study of coeliac disease. Gut 2002; 50: 624-8.

  • Bojković G Čaparević Z Ilić V Stojanović D Lalošević Đ Stojanović M. Prikaz slučaja: Morbus Coeliacus. Med Pregl 2002; LV (11-12): 529-31.

  • Briani C Samaroo D Alaedini A. Celiac disease: From gluten to autoimmunity. Autoimmun Rev 2008; 7: 644-50.

  • Copelton DA Valle G. »You don't need a prescription to go gluten-free«: The scientific self-diagnosis of celiac disease. Soc Sci Med 2009; 62: 623-31.

  • Green PHR Stavropoulos SN Panagi SG Goldstein SL McMahon DJ Absan H et al. Characteristics of Adult Celiac Disease in the USA: Results of a National Survey. Am J Gastroenterol 2001; 96 (1): 2001: 126-31.

  • Reeves GEM Squance ML Duggan AE Murugasu RR Wilson RJ Wong RC et al. Diagnostic accuracy of coeliac serological tests: a prospective study. Eur J Gastroenterol Hepatol 2006; 18 (5): 493-501.

  • Farrel RJ Kelly CP. Celiac sprue. N Engl J Med 2002; 346 (3): 180-8.

  • Alaedini A Green PHR. Narrative Review: Celiac Disease. Undestanding a Complex Autoimmune Disorder. Ann Int Med 2005; 142 (4): 289-99.

  • World Gastroenterology Organisation Practice Guidelines: Celiac Disease Available at: ( http://www.worldgastroenterology.org/celiac-disease.html

  • Hadithi M Peña AS. Current methods to diagnose the unresponsive and complicated forms of coeliac disease. Eur J Intern Med (2010) doi: 10.1016/j.ejim.2010.01.

  • Lewis NR Scott BB. Systemic review: the use of serology to exclude or diagnose coeliac disease (a comparison of endomysial and tissues transglutaminase antibody tests). Aliment Pharmacol Ther 2006; 24: 47-54.

  • Janković S. Medicina zasnovana na dokazima. Available at: http://www.medrat.edu.rs/Cirilica/Materijal/02.Medicina%20zasnovana%20na%20dokazima.pdf

  • Grujić V Jakovljević Đ eds. Primena statistike u medicinskim istraživanjima Prvo izdanje. Novi Sad: Medicinski fakultet; 1998.

  • Evans KE Malloy AR Gorard DA. Changing patterns of coeliac serology requests. Aliment Pharmacol Ther 2009; 29: 1137-42.

  • Reeves GEM Burns C Hall ST Gleeson M Lemmert K Clancy RL. The measurement of IgA and IgG transglutaminase antibodies in celiac disease: a comparison with current diagnostic methods. Pathology 2000; 32: 181-5.

  • Wolters V Vooijs-Moulaert AF Burger H Brooimans R De Schryver J Rijkers G et al. Human tissues transglutaminase enzyme linked immunosorbent assay outperforms both guinea pig based tissues transglutaminase assay and anti-endomysium antibodies when screening for celiac disease. Eur J Paediatr 2002; 161: 284-7.

  • Dietrich W Ehnis T Bauer M Donnel P Volta U Riecken EO et al. Identification of tissues transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797-801.

  • Hill PG Forsyth JM Semerari D Holmes GKT. IgA Antibodies to Human Tissue Transglutaminase: Audit of Routine Practice Confirms High Diagnostic Accuracy. Scand J Gastroenterol 2004; 11: 1078-82.

  • Wolff-Burgin A Dahlbom I Hadziselimović F Petersson CJ. Antibodies against tissue transglutaminase and endomysium in diagnosing and monitoring coeliac disease. Scand J Gastroenterolog 2002; 6: 685-91.

  • Cassella G D'Inca R Oliva L Daperno M Saladino V Zoli G et al. Prevalence of celiac disease in inflammatory bowel diseases: An IG-IBD multicentre study. Dig Liver Dis 2010; 42: 175-8.

  • Dahele A Ghosh S. Vitamin B12 Deficiency in Untreated Celiac Disease. Am J Gastroenterol 2001; 96 (3): 745-50.

  • Mijušković Z Radović V Pejović J Tukić Lj Marjanović S Stojanović J. Free light chains of immunoglobulin as a prognostic factor for some plasmaproliferative diseases. Journal of Medical Biochemistry 2011; 30: 293-301.

  • Ciacci C Cirillo M Giorgetti G Alfinito F Franchi A Pietralata M et al. Low Plasma Cholesterol: A Correlate of Nondiagnosed Celiac Disease in Adults with Hypochomic Anemia. Am J Gastroenterol 1999; 94 (7): 1888-91.

Search
Journal information
Impact Factor


IMPACT FACTOR 2018: 2,000
5-year IMPACT FACTOR: 1,075



CiteScore 2018: 1.47

SCImago Journal Rank (SJR) 2018: 0.523
Source Normalized Impact per Paper (SNIP) 2018: 0.581

Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 307 185 4
PDF Downloads 106 86 2